Abdominal Aortic Aneurysm (AAA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report

An Abdominal aortic aneurysm (AAA) is characterized by the enlargement of the lower segment of the aorta, the body’s primary blood supply vessel, which extends from the heart through the chest and abdomen. Several factors contribute to the formation of AAA, including inflammation weakening the aortic artery wall, advanced age (50+ for men, 60+ for women), a history of atherosclerosis, high blood pressure, elevated cholesterol, heart or peripheral vascular disease, and tobacco use. Those at the highest risk are men older than 60, smokers, Caucasians, and individuals with a first-generation relative who has had an AAA. Additional potential factors associated with AAA development include tears in the arterial wall, infections, and congenital connective tissue disorders. The diagnosis of an abdominal aortic aneurysm typically involves the use of ultrasound. However, a CT scan is required to determine its precise location, size, and impact on surrounding blood vessels, especially in symptomatic patients. The differential diagnosis for AAA includes Mesenteric ischemia, Peptic ulcer disease, Diverticulitis, Pyelonephritis, and Myocardial infarction. Treatment is recommended when the aneurysm diameter reaches 5 to 5.5 cm, shows rapid enlargement of more than 0.5 cm over six months, or becomes symptomatic. Open surgical repair via transabdominal or retroperitoneal approach has been the gold standard. The prognosis for AAA is grim, with an approximately 80% risk of death following a rupture. Most patients do not survive long enough to reach the hospital, and even with surgical intervention, the success rate for repairing a ruptured aneurysm is only 50%.
• It is important to note that each year in the USA, 200,000 people are diagnosed with an abdominal aortic aneurysm (AAA).

Thelansis’s “Abdominal Aortic Aneurysm (AAA) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Abdominal Aortic Aneurysm (AAA) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Abdominal Aortic Aneurysm (AAA) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Abdominal Aortic Aneurysm (AAA) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
Read more: Abdominal Aortic Aneurysm (AAA) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Tags: Abdominal Aortic Aneurysm (AAA), Abdominal Aortic Aneurysm (AAA) market outlook, Abdominal Aortic Aneurysm (AAA) competitive landscape, Abdominal Aortic Aneurysm (AAA) market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)